SpaceX recently completed a record IPO.

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 6.3% in the afternoon session after the European ...

Eli Lilly holds a dominant market share in the weight loss treatment category.

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43. We rate LLY a buy with a 90% confidence score.

The GLP-1 drug market is massive and still growing fast. Investing in a promising growth stock in the space could lead to ...

Eli Lilly has made some massive breakthroughs in pharmaceutical technology, but will it translate to money for investors? Read our forecast and find out.

ProQR Therapeutics has priced a registered direct offering of 27.6M ordinary shares at $1.81 per share, expecting to raise about $50M in gross proceeds before expenses. Separately ...

Most of the U.S. stock market rose after oil prices eased back to where they were before the war with Iran, but drops for AI ...

Eli Lilly (NYSE:LLY | LLY Price Prediction) just reported a quarter that should have sent bulls into a frenzy. Revenue grew ...

There are some good reasons why investors might want to avoid Eli Lilly (NYSE: LLY). For example, its price-to-earnings ratio is high at 40x, and its yield is very low at just 0.6%. But there are also ...

While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to ...